Incretin-Based Drugs Not Tied to Increased Risk of Acute Pancreatitis Among Diabetics: Study We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok Source link
Bi-Weekly Cofrogliptin Outperforms Daily DPP-4 Inhibitors in Type 2 Diabetes: Phase 2 Trial We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok Source link
Incretin-Based Diabetes Drugs Show No Added Risk of Pancreatitis but Slight Increase in Biliary Events, Study Finds We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok Source link
GLP-1 Receptor Agonists Reduce Cardiovascular and Kidney Risks in Lupus Patients with Type 2 Diabetes: Study We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok Source link
GLP1-RA Shows Protective Effects Against Gastrointestinal Complications in Diabetes Patients: Study We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok Source link
GLP-1 Receptor Agonists Linked to Improved Survival in Older Adults with Cancer and Type 2 Diabetes: Study We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok Source link